Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with Paclitaxel in Advanced Pancreatic Cancer
NCT01971034Phase 2Completed
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in pancreatic adenocarcinoma (PDAC), sponsored by Instituto do Câncer do Estado de São Paulo. Started Jun 2011; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01971034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01971034.